	US 12,233,044 B2
	Cannabidiol and chitosan compositions and methods of using the same
Noach Ben-Shalom, Tel-Aviv (IL); and Dror Robinson, Bat Yam (IL)
Assigned to MOR RESEARCH APPLICATIONS LTD., Tel Aviv (IL)
Filed by MOR RESEARCH APPLICATIONS LTD., Tel Aviv (IL)
Filed on Nov. 8, 2022, as Appl. No. 17/982,745.
Application 17/982,745 is a continuation of application No. 16/756,575, granted, now 11,679,094, previously published as PCT/IL2018/051119, filed on Oct. 18, 2018.
Claims priority of provisional application 62/573,813, filed on Oct. 18, 2017.
Prior Publication US 2023/0080363 A1, Mar. 16, 2023
This patent is subject to a terminal disclaimer.
Int. Cl. A61K 31/352 (2006.01); A61K 31/05 (2006.01); A61K 47/10 (2017.01); A61K 47/24 (2006.01); A61K 47/36 (2006.01); A61P 3/06 (2006.01)

CPC A61K 31/352 (2013.01) [A61K 31/05 (2013.01); A61K 47/10 (2013.01); A61K 47/24 (2013.01); A61K 47/36 (2013.01); A61P 3/06 (2018.01)]

18 Claims

1. A method for decreasing the blood concentration of: cholesterol, LDL, Triglycerides, or any combinations thereof, in a subject in need thereof, comprising administering to said subject a therapeutically effective amount of a pharmaceutical composition comprising: (a) cannabidiol (CBD) and (b) chitosan in a weight per weight ratio ranging from 1:5 to 1:80, thereby decreasing the blood concentration of: cholesterol, LDL, Triglycerides, or any combinations thereof, in said subject in need thereof.